Abstract
The conventional therapy for CNS GCTs is irradiation [73], administered either alone (mainly for germinomas) or with chemotherapy (for non-germinomatous GCTs). Germinomas are exquisitely radiosensitive; 65% to 95% 5-year survival rates have been reported for patients with germinomas when the treatment is irradiation alone. Non-germinomatous GCTs are less sensitive to irradiation and the 5-year survival rates for patients afflicted with them range from 20% to 56% [58,82]. Notwithstanding its effectiveness, cranial irradiation may lead to long-term sequelae, including intellectual deterioration, not only in children [27], but also in adults [24]. It may also lead to growth retardation, endocrine dysfunction [22], hearing loss and about a 12% incidence of secondary tumors [52]. Craniospinal irradiation carries the additional morbidity of growth arrest, marrow suppression and damage to the gonadal organs. Reports of long term survivors of CNS GCTs treated with irradiation emphasize its long-term cognitive effects, including difficulties with school and social interactions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Allen JC, Bosl G, Walker R (1985) Chemotherapy trials in recurrent primary intracranial germ cell tumors. J Neuro-Oncol 3: 147–152
Allen J (1987) Management of primary intracranial germ cell tumors of childhood. Pediatr Neurosci 13: 151–157
Allen JC, Kim JH, Packer RJ (1987) Neoadjuvant chemotherapy for newly diagnosed germ cell tumors of the central nervous system. J Neurosurg 67: 65– 70
Allen JC, Da Rosso RC, Donahue B et al (1994) A phase II trial of pre irradiation carboplatin in newly diagnosed germinoma of the central nervous system. Cancer 74: 940–944
Aprikian AG, Herr HW, Bajorin DF et al (1994) Resection of post chemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors. Cancer 74: 1329–1334
Balmaceda C, Finaly J, Heller G et al (1994) Prognostic factors at diagnosis in patients with primary central nervous system germ cell tumors: a report of an international collaborative trial of chemotherapy. Prog Proceed ASCO 13: 176 (abstr)
Balmaceda C, Finlay J, Rosemblum M et al (1995) Tumor markers in the evaluation of central nervous system germ cell tumors at diagnosis. Neurology 45: 450 (abstr)
Balmaceda C, Heller G, Rosenbaum M et al (1996) Chemotherapy without irradiation — a novel approach for newly diagnosed central nervous system germ cell tumors: results of an international cooperative trial. J Clin Oncol 14: 2908–2915
Balmaceda C, Merchant T, Heller G et al (1996) Retrieval of central nervous system germ cell tumors, treated with initial chemotherapy alone, following first relapse. Presented at the 7th International Symposium in Pediatric Neuro-Oncology, March 23, 1996
Baranzelli MC, Patte C, Bouffet E et al (1997) Nonmetastatic intracranial germinoma. The French Society of Pediatric Oncology experience. Cancer 80: 1792–1797
Baranzelli MC, Patte C, Bouffet E et al (1998) An attempt to treat pediatric intracranial AFP and BHCG secreting germ cell tumors with chemotherapy alone. SFOP experience with 18 cases. J Neuro Oncol 37: 229–239
Beyer J, Kramar A, Mandans R et al (1996) High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables. J Clin Oncol 14: 2638–2645
Biron P, Brunet-Mentigny M, Bayle J et al (1989) Cisplatin, VP-16 and ifosfamide and autologous bone marrow transplantation in poor prognosis non seminomatous germ cell tumors. Proc Am Soc Clim Oncol 8: 148
Bosl GJ, Geller NL, Cirrrincione C et al (1983) Multivariate analysis of prognostic variables in patients with metastic testicular cancer. Cancer Res 43: 3403–3407
Bosl GJ, Yagoda A, Whitmore WF Jr et al (1984) VP-16 and cisplatin in the treatment of patients with refractory germ cell tumors. Am J Clin Oncol 7: 327–330
Calaminus G, Bamberg M, Baranzelli MC et al (1994) Intracranial germ cell tumors: a comprehensive update of the European data. Neuropediatrics 25: 26–32
Calaminus G, Bamberg M, Harms D et al (1995) Intracranial germ cell tumors (GCTs): results of the MAKEI 89 therapy protocol. Med Ped Oncology 23: 233 (abstr)
Calaminus G, Andreussi L, Garre ML et al (1997) Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/ Italian Pilot Study (central nervous system germ cell tumors). Klin Pediatr 209: 222–227
Castaneda VL, Parmley RT, Geiser CF, Saldivar VA et al (1990) Postoperative chemotherapy for primary intracranial germ cell tumors. Med Ped Oncology 18: 299–303
Chan H, Humphreys R, Hendrick B, Chuang S et al (1984) Primary intracranial choriocarcinoma: a report of two cases and a review of the literature. Neurosurgery 14: 540–545
Chang TK, Wong TT, Huang B (1995) Combination chemotherapy with vinblastine, bleomycin, cisplatin and etoposide (VPBE) in children with primary intracranial germ cell tumors. Med Pediatr Oncol 24: 368–372
Constine LS, Woolf PD, Cann D et al (1993) Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 328: 87–94
Cooper K, Bajorin D, Shapiro W et al (1990) Decompression of epidural metastases from germ cell tumors with chemotherapy. J Neuroncol 8: 275– 280
Crossen JR, Garwood D, Glatstein E et al (1994) Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12: 627–642
Demeocq F, Baranzelli MC, Renier D et al (1988) Traitement des tumeurs germinales malignes intracraniennes de l’enfant. Presse Med 17: 2183– 2185
Dodion P, Sanders C, Georgers P, Kenis Yet al (1988) In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin. Cancer Chemother Pharmacol 22: 80–82
Duffner PK, Cohen ME, Thomas PR et al (1985) The long-term effects of cranial irradiation on the central nervous system. Cancer 56: 1841–1846
De Tribolet N, Barrelet L (1977) Successful chemotherapy of pinealoma. Lancet XX: 1228–1229
Edwards MSB (1988) Pineal region tumours in children. J Neurosurg 68: 689– 697
Einhorn LH, Donohue J (1977) Cis-diamminedichloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87: 293–298
Ely an SAG, Traish D, Ashley S et al (1993) The management of primary CNS GCT with chemotherapy: Presented at the Third International Neurol-Oncology Conference, Royal Mardsden Hospital, London, England, April 1993
Gardner S, Dunkel I, Bayer L et al (1996) Autologous stem cell rescue using peripheral blood cells versus bone marrow in patients with recurrent malignant brain tumors. Exp Hematol 24: 1043 (abstr)
Flamant F, Baranzelli MC, Lemerle J (1990) Treatment of malignant germ cell tumors in children: experience of the Institute Gustave Roussy and the French Society of Pediatric Oncology. Crit Rev Oncol Hematol 10: 90–110
Gaynon P, Ettinger L, Baum E et al (1990) Carboplatin in childhood brain tumors. A children’s cancer study group phase II trial. Cancer 66: 2465– 2469
Ginsberg S, Kirshner J, Reich S et al (1981) Systemic chemotherapy for a primary germ cell tumor of the brain — a pharmacokinetic study. Cancer Treat rep 65: 477–483
Graziano S, Paolozzi F, Rudolph A et al (1987) Mixed germ cell tumors of the pineal region. Case report. J Neurosurg 66: 300–304
Haase J, Nielsen K (1979) Value of tumor markers in the treatment of endodermal sinus tumors and choriocarcinomas in the pineal region. Neurosurgery 5: 485–488
Hayashida O, Kageyama N, Ogata N, Okumura T et al (1989) Combination chemotherapy with etoposide and cisplatin to intracranial germ cell tumors: a preliminary report. Pediatr Neurosurg 14: 150–151 (abstr)
Hermann H, Westphal M, Winkler K et al (1994) Treatment of nongerminomatous germ-cell tumors of the pineal region. Neurosurgery 34: 524– 529
Hoffman HJ, Otsubo H, Hendrick EB et al (1991) Intracranial germ cell tumors in children. J Neurosurg 74: 545–551
Itoyama Y, Kochi M, Kuratsu J et al (1995) Treatment of intracranial non-germinomatous malignant germ cell tumors producing alfa-fetoprotein. Neurosurgery 36: 459–464
Jelsma RK, Carroll M (1989) Brain metastasis from non seminomatous germ cell tumors of the testis: case report and review of the role of surgery. Neurosurgery 25: 814–819
Jennings MT, Gelman R, Hochberg F (1985) Intracranial germ cell tumors: natural history and pathogenesis. J Neurosurg 63: 155–167
Jereb B, Zupancic N, Petric J (1990) Intracranial germinoma: report of seven cases. Pediatr Hematol Oncol 7: 183–88
Jeremic B, Grujicic D, Jevremovic S et al (1992) Carboplatin and etoposide chemotherapy regimen for recurrent malignant gliomas: a phase II study. J Clin Oncol 10: 1074–1077
Kalifa C (1997) Personal communication
Kida Y, Kobayashi T, Yoshida J et al (1986) Chemotherapy with cisplatin for AFP-secreting germ-cell tumors of the central nervous system. J Neurosurg 65: 470–475
Kobayashi T, Yoshida J, Ishimaya J et al (1989) Combination chemotherapy with cisplatin and etoposide for malignant intracranial germ cell tumors: an experimental and clinical study. J Neurosurg 70: 676–681
Kobayashi T, Yoshida J, Sugita K et al (1989) Combination chemotherapy with cisplatin and etoposide for intracranial germ cell tumors. Pediatr Neurosurg 24: 150
Kretschmar CS (1997) Germ cell tumors of the brain in children: a review of current literature and advances in therapy. Cancer Investigation 15: 187–198
Lee ACW, Chan GCF, Fung CF et al (1995) Paradoxical response of a pineal immature teratoma to combination chemotherapy. Medical and Pediatric Oncol 24: 53–57
Li FP, Cassady JR, Jaffe N (1975) Risk of second tumors in survivors of childhood cancer. Cancer 35: 1230–1235
Logothetis CJ, Samuels ML, Trindade A (1982) The management of brain metastases in germ cell tumors. Cancer 49: 12–18
Mahoney D, Strather D, Carmitta B et al (1996) High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot Pediatric Oncology Group study. J Clin Oncol 14: 382–388
Matsukado Y (1986) The Japanese intracranial germ cell tumor study group: cisplatin, vinblastine, and bleomycin (PVB) combination chemotherapy in the treatment of intracranial malignant germ cell tumors — a preliminary report of a phase II study. Gan No Rinsho 32: 1387–1393
Matsutani M, Takakura K, Sano K (1987) Primary intracranial germ cell tumors: pathology and treatment. Prog Exp Tumor Res 30: 307–312
Matsutani, Asai A, Fujimaki T, Nakamura O (1993) Successful treatment of recurrent malignant germ cell tumors: report of two cases. Neurosurgery 33: 901–906
Matsutani M, Sano K, Takakura K et al (1997) Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg 86: 446–455
Modak S, Gardner S, Dunkel I et al (1997) High dose chemotherapy with autologous stem cell rescue in patients with recurrent central nervous system germ cell tumors. Presented at: Childhood Cancer into the 21st Century: An international conference to mark the 20th anniversary of the UKCCSG, London, United Kingdom, March 1997
Motzer R, Mazumdar M, Bosl G et al (1996) High-dose carboplatin, etoposide and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity. J Clin Oncol 14: 1098–1105
Motzer R, Gulati S, Crown J et al (1990) High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors: early intervention is better tolerated. Cancer 69: 550–556
Murphy BA, Motzer RJ, Mazumdar M et al (1994) Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patientstreated with cisplatin and ifosfamide salvage chemotherapy. Cancer 73:2520–2526
Nashold JRB, Oakes WJ, Friedman HS et al (1994) Management of pineal non-germinoma germ cell tumor with residual teratoma and normal alphafetoprotein. Med Pediatr Oncol 22: 137–139
Nichols C, Andersen J, Lazarus H et al (1992) High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. J Clin Oncol 10: 558–563
Oi S, Matsumoto S (1992) Controversy pertaining to the therapeutic modalities for tumors of the pineal region: worldwide survey of different patient populations. Child Nervous System 8: 332–336
Packer R, Sutton L, Rorke L et al (1984) Intracranial embryonal carcinoma. Cancer 54: 520–524
Patel S, Buckner JC, Smithson WA, et al (1992) Cisplatin-based chemotherapy in primary central nervous system germ cell tumors. J Neuro-Oncol 12: 47–52
Pinkerton CR, Broadbent V, Horwich A et al (1990) ‘JEB’ - a carboplatin based regimen for malignant germ cell tumors in children. Br J Cancer 62: 267–262
Plowman N, Sebag-Montefiore D, Kingston J (1993) “Central nervous system friendly” chemotherapy for the treatment of intracranial germ cell tumors. Proc ASCO 12: 177 (abstr)
Robertson PL, DaRosso RC, Allen JC (1997) Improved modality of intracranial non-germinoma germ cell tumors with multimodality therapy. J Neuro-Oncol 32: 71–80
Rustin GJS, Newlands ES, Bagshawe KD et al (1986) Successful management of metastatic and primary germ cell tumors in the brain. Cancer 57: 2108–2113
Sakai N, Yamada H, Andoh T, Hirata T, Shimizu K, Shinoda J (1988) Primary intracranial germ-cell tumors. Retrospective analysis with special reference to long-term results of treatment and the behavior of rare types of tumors. Acta Oncol 27: 43–50
Salazar OM, Castro-Vita H, Bakos RS, Feldstein ML, Rubin P (1979) Radiation therapy for tumors of the pineal region. Int J Radiat Oncol Biol Phys 5: 491– 499
Siegal T, Pfeffer R, Catane et al (1983) Successful chemotherapy of recurrent intracranial germinoma with spinal metastases. Neurology 33: 631–633
Siegert W, Beyer J, Strohscheer I et al (1994) High-dose carboplatin, etoposide and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ-cell cancer: a phase II study. J Clin Oncol 12: 1223–1231
Skinner R (1993) Treatment of intracranial non-germinomatous germ cell tumors in children with chemotherapy alone. Presented at the Third International Neuro-Oncology Conference, Royal Mardsden Hospital, London, England, April 1993
Spiegel AM, Di Chiro G, Gorden P et al (1976) Diagnosis of radiosensitive hypothalamic tumors without craniotomy. Ann Intern Med 85: 290–293
Thomas G (1985) Controversies in the management of testicular seminoma. Cancer 5: 2296–2302
Watterson J, Priest JR (1989) Control of extraneural metastasis of a primary intracranial nongerminomatous germ-cell tumor. J Neurosurg 71: 601–604
Williams SD, Birch R, Einhorn LH et al (1987) Treatment of disseminated germ cell tumors with chemotherapy with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316: 1435–1440
Wolden SL, Wara WM, Larson DA et al (1995) Radiation therapy for primary intracranial germ-cell tumors. Int J Radiat Oncol Biol Phys 32: 943–947
Yoshida J, Sugita K, Kobayashi T et al (1993) Prognosis of intracranial germ cell tumors: effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16). Acta Neurochir (Wien) 120: 111–117
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag/Wien
About this chapter
Cite this chapter
Balmaceda, C., Modak, S., Finlay, J. (1998). Chemotherapy for CNS GCTs. In: Sawamura, Y., Shirato, H., de Tribolet, N. (eds) Intracranial Germ Cell Tumors. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6821-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6821-9_11
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7414-2
Online ISBN: 978-3-7091-6821-9
eBook Packages: Springer Book Archive